What medicine is Venetoclax?

Venetoclax/Venetoclax (Venetoclax) is a targeted therapy for hematological malignancies such as B cell lymphoma and chronic lymphocytic leukemia (CLL). It belongs to the Bcell lymphoma/leukemia-2 (BCL-2) inhibitor category, which promotes the death of abnormal white blood cells by specifically inhibiting the overexpressed BCL-2 protein in the body.

BCL-2 is a protein that regulates apoptosis (programmed cell death). It is overexpressed in some cancers, leading to abnormal cell survival. The mechanism of action of venetoclax is to block the function of BCL-2 protein, causing tumor cells to undergo programmed cell death, thereby inhibiting the growth and spread of tumors.

Venetoclax/Venetoclax is commonly used to treat patients with refractory or relapsed chronic lymphocytic leukemia (CLL) and some patients with non-Hodgkin lymphoma. It may also play a role in other types of leukemia and lymphoma.

When using venetoclax/venetoclax, doctors usually develop a personalized treatment plan based on the patient's specific situation and type of disease. Although venetoclax has brought significant clinical benefits to some patients, its use may still be associated with some side effects, so patients need to be closely monitored and follow their doctor's recommendations during use.

Venetoclax/Venetoclax has been launched in China and has been included in medical insurance, and patients can purchase it domestically. Specifications100mg*14tablet price is 5000Around RMB 1,000. Please consult the local hospital pharmacy for specific prices. There are original drugs and generic drugs abroad. The Turkish version of Venetoclax /original drug /Venetoclax on the market overseas, specifications: 100mg*112 tablets, the price per box is about more than 10,000. Foreign generic drugs are relatively cheaper. For example, the generic drugs sold in Laos and Bangladesh are priced at about more than 4,000 yuan for 100mg*120 tablets. The ingredients of original drugs and generic drugs are basically the same.